Chemistry and chemical biology of taxane anticancer agents

Chemical Record : an Official Publication of the Chemical Society of Japan ... [et Al.]
M L Miller, Iwao Ojima

Abstract

Taxol (paclitaxel) and Taxotere (docetaxel) are currently considered to be among the most important anticancer drugs in cancer chemotherapy. The anticancer activity of these drugs is ascribed to their unique mechanism of action, i.e., causing mitotic arrest in cancer cells, leading to apoptosis through inhibition of the depolymerization of microtubules. Although both paclitaxel and docetaxel possess potent antitumor activity, treatment with these drugs often results in a number of undesirable side effects, as well as multidrug resistance (MDR). Therefore, it has become essential to develop new anticancer agents with superior pharmacological properties, improved activity against various classes of tumors, and fewer side effects. This paper describes an account of our research on the chemistry of paclitaxel and taxoid anticancer agents at the biomedical interface, including: 1. The structure-activity relationship (SAR) study of taxoids leading to the development of the "second-generation" taxoids, which possess exceptional activity against drug-resistant cancer cells expressing the MDR phenotype. 2. Development of fluorinated taxoids to study the bioactive conformation of paclitaxel and photoaffinity labeling taxoids for mapping ...Continue Reading

References

Feb 22, 1979·Nature·P B SchiffS B Horwitz
May 20, 1992·Journal of the National Cancer Institute·S RaoI Ringel
Feb 20, 1991·Journal of the National Cancer Institute·I Ringel, S B Horwitz
Oct 10, 1991·Nature·C Anderson
Mar 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·P B Schiff, S B Horwitz
Feb 17, 1994·Nature·K C NicolaouK Paulvannan
Jan 1, 1993·Annual Review of Biochemistry·M M Gottesman, I Pastan
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M A JordanL Wilson
Sep 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B I Sikic
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·T C ChouS J Danishefsky
Sep 11, 1998·Journal of Medicinal Chemistry·D G KingstonK A Johnston
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·T C ChouS J Danishefsky
Jan 1, 1999·Bioorganic & Medicinal Chemistry Letters·I OjimaR J Bernacki
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·I OjimaS J Danishefsky
Jul 21, 1999·Cancer Chemotherapy and Pharmacology·H M McDaidS J Danishefsky
Jan 5, 2000·Bioorganic & Medicinal Chemistry Letters·I OjimaR J Bernacki

❮ Previous
Next ❯

Citations

Sep 5, 2002·Biomedical Chromatography : BMC·K P MadhusudananS P Jain
Aug 2, 2005·Naunyn-Schmiedeberg's Archives of Pharmacology·Marie EhrlichovaIvan Gut
Aug 3, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·Marie EhrlichováIvan Gut
Mar 9, 2012·Analytical and Bioanalytical Chemistry·Katharina HartmannJürgen Popp
Jun 1, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Bernd J KrauseMarkus Schwaiger
Jul 16, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Mohamed Kamel HassanNoriaki Sakuragi
Dec 22, 2011·Journal of Experimental & Clinical Cancer Research : CR·Mohamed K HassanNoriaki Sakuragi
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Judith HughCharles Vogel
Jan 29, 2011·International Journal of Women's Health·Sanjeev KumarAdnan Munkarah
Jun 4, 2008·Future Oncology·Stacy L Moulder
Mar 13, 2014·Cancer Treatment Reviews·Nuno A FonsecaJoão N Moreira
Dec 2, 2010·Women's Health·Stacy Moulder
May 27, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Claudie Bourgaux, Patrick Couvreur
Dec 15, 2012·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Keyuna S CameronPaul B Tchounwou
May 14, 2004·Neoplasia : an International Journal for Oncology Research·Yiwei LiFazlul H Sarkar
Aug 29, 2007·The Breast : Official Journal of the European Society of Mastology·Clifford HudisChau Dang
Apr 7, 2004·British Journal of Pharmacology·Shanthala PadarRoshanak Rahimian
Sep 22, 2012·The Prostate·Chengfei LiuAllen C Gao
Mar 23, 2011·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Yu-Jen ChiuJai-Sing Yang
Jan 13, 2011·Scandinavian Journal of Immunology·Y ZhuY W Chu
Apr 7, 2005·The Lancet Oncology·Alberto MonteroVicente Valero
May 4, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Emmanuel A HoMicheline Piquette-Miller
Aug 21, 2014·International Journal of Pharmaceutics·Mei-Hua QuJian-Ting Long
Oct 3, 2003·Chemistry & Biology·David E RootBrent R Stockwell
Sep 25, 2016·Toxicology and Applied Pharmacology·Vlasta Němcová-FürstováJan Kovář
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Clifford Hudis
May 10, 2005·Expert Review of Anticancer Therapy·Sarah P Blagden, Stan B Kaye
Jan 1, 2012·ISRN Otolaryngology·Wei GaoThian-Sze Wong
Aug 14, 2018·Journal of Labelled Compounds & Radiopharmaceuticals·Seth JonesVolker Derdau
Dec 29, 2006·Chemistry & Biodiversity·Bekir KarligaNaciye Talinli
Mar 27, 2007·Chemistry : a European Journal·María J AldegundeJuan R Granja

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Clinical Chemistry and Laboratory Medicine : CCLM
Raphaël GeneyIwao Ojima
International Journal of Urology : Official Journal of the Japanese Urological Association
Guru Sonpavde, Cora N Sternberg
Annals of Oncology : Official Journal of the European Society for Medical Oncology
S SofroniadouH P Kalofonos
© 2021 Meta ULC. All rights reserved